These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 4697470

  • 1. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar 02; 15(5):21-3. PubMed ID: 4697470
    [No Abstract] [Full Text] [Related]

  • 2. L-dopa. II.
    Br Med J; 1970 Nov 28; 4(5734):541-2. PubMed ID: 4099003
    [No Abstract] [Full Text] [Related]

  • 3. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK.
    Acta Neurol Scand Suppl; 1972 Nov 28; 51():59-103. PubMed ID: 4576076
    [No Abstract] [Full Text] [Related]

  • 4. A second report on Levodopa.
    Med Lett Drugs Ther; 1969 Sep 05; 11(18):73-5. PubMed ID: 5394281
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic uses and side effects of L-dopa.
    Boshes B.
    Adv Intern Med; 1972 Sep 05; 18():219-49. PubMed ID: 4576081
    [No Abstract] [Full Text] [Related]

  • 6. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E.
    Practitioner; 1972 Apr 05; 208(246):499-504. PubMed ID: 5031037
    [No Abstract] [Full Text] [Related]

  • 7. [Conservative therapy in the Parkinson syndrome].
    Birkmayer W.
    Wien Med Wochenschr; 1971 Nov 13; 121(46):827-9. PubMed ID: 5138823
    [No Abstract] [Full Text] [Related]

  • 8. L-Dopa treatment in Parkinson's Disease.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1970 Nov 13; 4(6):348-69. PubMed ID: 4932969
    [No Abstract] [Full Text] [Related]

  • 9. [Medical treatment of Parkinson's disease].
    Castaigne P, Rondot P, Ribadeau-Dumas JL.
    Ann Med Interne (Paris); 1972 Apr 13; 123(4):357-64. PubMed ID: 5077040
    [No Abstract] [Full Text] [Related]

  • 10. [Drug therapy of Parkinson's diseases].
    Lhermitte F, Degos CF.
    Acquis Med Recent; 1972 Apr 13; ():73-80. PubMed ID: 4667798
    [No Abstract] [Full Text] [Related]

  • 11. L-dopa therapy in Parkinson's disease.
    Lipman IJ.
    Va Med Mon (1918); 1971 May 13; 98(5):242-8. PubMed ID: 4931138
    [No Abstract] [Full Text] [Related]

  • 12. [Indications and results of monoamine treatment in parkinsonian syndromes].
    Boudin G, Pépin B, Guillard A, Fabiani JM, Haguenau M.
    Rev Neurol (Paris); 1972 Jul 13; 127(1):79-97. PubMed ID: 4520464
    [No Abstract] [Full Text] [Related]

  • 13. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS, Bauer RB, Rosenbaum H.
    Geriatrics; 1971 Aug 13; 26(8):61-70. PubMed ID: 5096462
    [No Abstract] [Full Text] [Related]

  • 14. Parkinson's disease treated with L-dopa. Three-year follow-up report.
    Mones RJ.
    N Y State J Med; 1972 Nov 15; 72(22):2749-50. PubMed ID: 4510706
    [No Abstract] [Full Text] [Related]

  • 15. [The current treatment of Parkinson's disease].
    Gonce M, Barbeau A.
    Rev Med Liege; 1976 Oct 10; 31(19):563-73. PubMed ID: 790511
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levodopa in Parkinsonism.
    Weiss JL, Chase TN.
    Drugs; 1971 Oct 10; 2(4):257-61. PubMed ID: 4948349
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.